This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEH9B0HD_L.jpg
The healthcare conglomerate did not immediately name Stoffels’ successor.
The announcement marks the second top management change at J&J (NYSE:JNJ) in recent months. In August, the company said Joaquin Duato will succeed long-standing Chief Executive Officer Alex Gorsky.
Stoffels, who worked at J&J’s Janssen unit in the early 1990s, re-joined J&J in 2002 when the drugmaker acquired Virco and Tibotec, a Belgium-based drug developer, to expand its pipeline for HIV drugs.
